Physician profile
David Alarcon
NPI 1912491226
$712.85
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $582 · 2024: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $203.94 | 2023-2024 | Rexulti |
| Shield Therapeutics INC | $86.77 | 2023 | Accrufer |
| Abbvie INC. | $83.99 | 2023-2024 | Linzess, Creon, Viberzi |
| Takeda Pharmaceuticals U.S.A., INC. | $69.55 | 2023 | Trintellix |
| Astrazeneca Pharmaceuticals LP | $53.75 | 2023-2024 | Breztri |
| Otsuka America Pharmaceutical, INC. | $46.49 | 2023-2024 | Rexulti |
| Pfizer INC. | $37.17 | 2024 | |
| Dynavax Technologies Corporation | $32.52 | 2023 | Heplisav-B |
| Lilly USA, LLC | $25.65 | 2023 | Mounjaro |
| Idorsia Pharmaceuticals US INC | $20.06 | 2023 | Quviviq |
| Sage Therapeutics, LLC | $19.95 | 2023 | |
| Sanofi Pasteur INC. | $18.92 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Alarcon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.